GENE ONLINE|News &
Opinion
Blog

Keytruda
Trials & Approvals Anti-PD-1
Merck’s Anti-PD1 Therapy Receives Second FDA Approval for Esophageal Carcinoma
2021-03-25
M&A Autoimmune Disease
Merck Acts on its Post-Keytruda Plan, Spends $1.85B to Acquire Pandion for Autoimmune Therapies
2021-02-26
Trials & Approvals PD-1 Inhibitor
Libtayo’s Second Approval in One Month Sets Up Lung Cancer Duel with Merck’s Keytruda
2021-02-24
Trials & Approvals Renal Cell Carcinoma
Merck, Eisai’s Combo Therapy Registers Superiority against Pfizer’s Drug in Kidney Cancer Trial
2020-11-15
R&D CAR-T Technology
First Non-Gene Edited CAR-T to Partner with Merck’s Blockbuster Against Colorectal Cancer
2020-10-01
Trials & Approvals ESCC
Keytruda Receives Two New Approvals in Japan
2020-08-30
Weekly Asia Highlights- South Korea and Australia
2020-08-13
Trials & Approvals Cancer
Keytruda Wins Big in China, Now Approved for Esophageal Squamous Cell Carcinomas
2020-06-26
R&D
ASCO 2020: Keytruda Shines as New Quality of Care in Treating metastatic Colorectal Cancer
2020-06-03
R&D
ASCO 2020: Keytruda Chemo Combo Show Significant Benefit in PD-L1 Expressing mTNBC
2020-06-03
Technology
What to Expect from the ASCO20 Virtual Program
2020-05-29
Technology
AACR 2020 – Changing the Immunotherapy Paradigm
2020-05-08
Trials & Approvals
AACR Conference – Major Highlights of Immunotherapy Clinical Trials
2020-04-30
R&D
AACR 2020 Conference – Recent Advances in Breast Cancer Treatments
2020-04-29
R&D
AACR 2020 Conference – Advances in the Field of Lung Cancer Targeted Therapies
2020-04-28
1 2 3
LATEST
Pfizer’s Q1 2024 Revenue Declines, Offset by Strong Performance of Non-COVID-19 Products
2024-05-03
Novo Nordisk Revises Outlook: Reports 24% Growth in Q1 2024 Sales, Reaching DKK 65.3 Billion
2024-05-03
UC Riverside Scientists Unveil RNA-based Vaccine Strategy, Potentially Avoiding Endless Booster Shots
2024-05-02
Lilly’s Q1 2024 Financial Report: Full-Year Revenue Outlook Raised by $2 Billion, with a 67% Net Income Increase
2024-05-02
Taiwan Breakthrough: Next-Generation Sequencing Now Covered in Health Insurance, Benefitting 20,000 Cancer Patients Annually
2024-05-02
CellTech Accelerator and Cyto-Facto Inc. Forge Strategic Partnership to Advance CGT Industry Growth
2024-04-29
Kaiser’s Data Breach: 13.4 Million Affected in Healthcare Conglomerates Privacy Crisis
2024-04-26
READ MORE
EVENT
SEE MORE
Newsletter

Subscribe to receive updates.

SIGN UP
Facebook
Youtube
Twitter
Linkedin
About
Explore
More
© 2024 GeneOnline
Privacy Policy | Terms of Service
Privacy Policy | Terms of Service
  • Subscribe to our newsletter and dive into the world of biopharma with us.
SIGN UP
x
Scroll to Top